Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03333616 |
| Title | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Diego Moores Cancer Center | La Jolla | California | 92093 | United States | Details | |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |